The relationship between pharmacodynamics and pharmacokinetics in asthmatic children receiving a sustained-release formulation of theophylline.
Pharmacodynamic response as well as serum and saliva concentrations of theophylline were monitored in 15 children under a long term theophylline treatment. Respiratory parameters, such as vital capacity and total bronchial resistance all related to bronchodilatation, were measured by use of a bodyplethysmograph. Measurements were performed before treatment and during the steady state with respect to serum levels. Due to small differences between peak and trough concentrations, no correlations between serum concentrations and respiratory parameters were found during the steady state. However, some important respiratory parameters exhibit considerable differences with respect to pretreatment values. In conclusion, one can state that during the steady state, theophylline exerts a constant influence on bronchodilatation which depends only slightly on the concentration range achieved.
D000293:Adolescent; D000403:Airway Resistance / Q000187:drug effects; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology; D002648:Child; D003692:Delayed-Action Preparations; D005260:Female; D005541:Forced Expiratory Volume; D006207:Half-Life; D006801:Humans; D007700:Kinetics; D008297:Male; D012129:Respiratory Function Tests; D012463:Saliva / Q000378:metabolism; D013806:Theophylline / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use*; D013997:Time Factors
D003692:Delayed-Action Preparations; D013806:Theophylline